The science has proven that gene therapies are effective treatments, and they have given hope to patients and their families ...
Orna will receive a $65m upfront payment and is eligible to receive potential milestone payments and royalties.
Company Making Additions to Executive Team and Advisory Board to Support Significant Commercial MomentumLONDON, Jan. 09, 2025(Ori), a leader in cell and gene therapy (CGT) manufacturing technology, to ...
The global Cell Therapy Technologies market, valued at US$3.89 billion in 2023, is forecasted to grow at a robust CAGR of 11.0%, ...
Discover why Danaher is a strong investment choice with its wide moat business model, M&A strategy, and growth potential for ...